This is the authors' abstract. We don't add key points for this paper.
Two hundred and forty‐nine sera derived from African donors suffering from a variety of malignant diseases were examined for EBV‐related antibody levels. When divided into three major subgroups (lymphoproliferative tumours, carcinoma and sarcoma) none of the mean titres approached the high anti‐VCA, anti‐MA or anti‐EA levels characteristic for Burkitt's lymphoma (BL) or nasopharyngeal carcinoma (NPC). On breaking down the material further into specific diagnostic or pathological subgroups, similar low mean values were found, except for small groups of plasma cell tumours and carcinomas of the palate (with high anti‐VCA and anti‐MA) and osteogenic sarcoma (with moderately high anti‐MA). The data do not support a regular association of high anti‐EBV titres with malignant disease in general and thus reaffirm the special position of BL and NPC in this respect.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Schryver et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: